Hospira Bleomycin Sulphate for Injection, USP 15 U, vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

bleomycin sulfate, Quantity: 15000 IU

Mevcut itibaren:

Hospira Australia Pty Ltd

INN (International Adı):

bleomycin sulfate

Farmasötik formu:

Injection, powder for

Kompozisyon:

Excipient Ingredients:

Uygulama yolu:

Intraarterial, Intracavitary, Intramuscular, Intravenous, Subcutaneous

Paketteki üniteler:

1 X 10 mL vial

Sınıf:

Medicine Listed (Export Only)

Reçete türü:

Not scheduled. Not considered by committee

Terapötik endikasyonlar:

Squamous cell carcinoma: skin, larynx and paralarynx, penis, cervix and vulva. Lung cancer and cervical carcinoma. Lymphomas: Hodgkin's lymphoma (no longer treatable by bone marrow depressant agents) and non-Hodgkin's lymphoma including reticulum cell sarcoma and lymphosarcoma. Testicular Carcinoma: Embryonal cell carcinoma, choriocarcinoma, and teratocarcimona. Pleurodysis and pleural fluid accumulation. Renal carcinomas and soft tissue sarcomas.

Ürün özeti:

Visual Identification: A white to cream coloured lyophilised powder or plug; Container Type: Vial; Container Life Time: 2 Years

Yetkilendirme durumu:

Listed (Export Only)

Yetkilendirme tarihi:

2006-03-10